马拉维综合慢性病照护中心抑郁症阶梯式照护:阶梯楔形整群随机试验研究方案
本研究在马拉维Neno区14家HIV诊所开展阶梯楔形整群随机试验,评估将小组式问题管理Plus(group PM+)联合抗抑郁药物治疗(ADT)的阶梯式抑郁照护模型与常规照护相比,对420名中重度抑郁成人抑郁症状、功能损害及整体健康的影响,并评估成本效果。
要点
- 在HIV诊所平台整合阶梯式抑郁照护,针对中重度抑郁成人。
- 采用阶梯楔形整群随机设计,14家机构分五步在15个月内推广。
- 主要结局为抑郁症状、功能损害和整体健康,每3个月随访至12个月。
核心结论
- 该试验将比较循证抑郁照护模型与常规照护对抑郁症状缓解及慢性病躯体健康结局的效果。
- 若确定具有成本效果,该模型可为马拉维其他地区及其他高HIV感染低资源环境提供整合抑郁照护的范例。
研究设计与样本
- 阶梯楔形整群随机对照试验,在马拉维Neno区14家卫生机构开展。
- 纳入420名经PHQ-9和MINI评估为中重度抑郁的成人。
- 14家机构随机分五步在15个月期间推广阶梯式抑郁照护模型。
关键数值与推荐
- 干预为小组式问题管理Plus(group PM+)联合抗抑郁药物治疗(ADT)的阶梯式模型。
- 主要结局为抑郁症状、功能损害和整体健康,每3个月测量至12个月随访。
- 次要结局包括HIV病毒载量、ART依从性、糖尿病A1C水平、治疗依从性、收缩压及治疗依从性。
- 成本效果以增量成本效果比(ICER)与无干预模型的基线慢性病服务比较。
临床怎么用
- 在HIV诊所等慢性病照护平台整合阶梯式抑郁筛查与治疗,可能扩大抑郁治疗覆盖。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Malawi is a low-income country in sub-Saharan Africa that has limited resources to address a significant burden of disease-including HIV/AIDS. Additionally, depression is a leading cause of disability in the country but largely remains undiagnosed and untreated. The lack of cost-effective, scalable solutions is a fundamental barrier to expanding depression treatment. Against this backdrop, one major success has been the scale-up of a network of more than 700 HIV clinics, with over half a million patients enrolled in antiretroviral therapy (ART). As a chronic care system with dedicated human resources and infrastructure, this presents a strategic platform for integrating depression care and responds to a robust evidence base outlining the bi-directionality of depression and HIV outcomes. METHODS: We will evaluate a stepped model of depression care that combines group-based Problem Management Plus (group PM+) with antidepressant therapy (ADT) for 420 adults with moderate/severe depression in Neno District, Malawi, as measured by the Patient Health Questionnaire-9 (PHQ-9) and Mini-International Neuropsychiatric Interview (MINI). Roll-out will follow a stepped-wedge cluster randomized design in which 14 health facilities are randomized to implement the model in five steps over a 15-month period. Primary outcomes (depression symptoms, functional impairment, and overall health) and secondary outcomes (e.g., HIV: viral load, ART adherence; diabetes: A1C levels, treatment adherence; hypertension: systolic blood pressure, treatment adherence) will be measured every 3 months through 12-month follow-up. We will also evaluate the model's cost-effectiveness, quantified as an incremental cost-effectiveness ratio (ICER) compared to baseline chronic care services in the absence of the intervention model. DISCUSSION: This study will conduct a stepped-wedge cluster randomized trial to compare the effects of an evidence-based depression care model versus usual care on depression symptom remediation as well as physical health outcomes for chronic care conditions. If determined to be cost-effective, this study will provide a model for integrating depression care into HIV clinics in additional districts of Malawi and other low-resource settings with high HIV prevalence. TRIAL REGISTRATION: ClinicalTrials.gov NCT04777006 . Registered on 1 March, 2021.
引用
- McBain RK, Mwale O, Ruderman T, et al. Stepped care for depression at integrated chronic care centers (IC3) in Malawi: study protocol for a stepped-wedge cluster randomized controlled trial. Trials. 2021. PMID: 34530894. doi:10.1186/s13063-021-05601-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。